| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,901 |
6,244 |
$356K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,073 |
7,616 |
$223K |
| 11721 |
|
15,512 |
12,634 |
$130K |
| 73630 |
|
8,299 |
5,063 |
$95K |
| 11750 |
|
328 |
195 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,213 |
918 |
$15K |
| 73620 |
|
1,428 |
836 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
331 |
259 |
$9K |
| 20550 |
|
267 |
177 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
30 |
27 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
48 |
38 |
$2K |
| 11056 |
|
699 |
616 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
805 |
632 |
$560.01 |
| 99199 |
Unlisted special service, procedure or report |
87 |
87 |
$445.00 |
| 11720 |
|
68 |
55 |
$380.13 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
284 |
205 |
$329.64 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
28 |
12 |
$212.46 |
| 11055 |
|
69 |
63 |
$137.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
12 |
$0.80 |
| L3260 |
Surgical boot/shoe, each |
15 |
12 |
$0.00 |
| 3044F |
|
27 |
26 |
$0.00 |